Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Verastem Inc (VSTM)

Verastem Inc (VSTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Verastem: Q1 Earnings Snapshot AP - Tue May 13, 3:50PM CDT

Verastem: Q1 Earnings Snapshot

VSTM : 8.31 (+11.10%)
Verastem: Q4 Earnings Snapshot AP - Thu Mar 20, 3:17PM CDT

Verastem: Q4 Earnings Snapshot

VSTM : 8.31 (+11.10%)
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge Newswire.ca - Sat Mar 8, 6:33AM CST

/CNW/ -- As the global cancer crisis intensifies, the demand for breakthrough treatments is reaching new heights. Statista data projects a 20% rise in annual...

ONCY : 0.4184 (+4.11%)
EXEL : 42.39 (-1.10%)
ONC.TO : 0.55 (-1.79%)
ALXO : 0.4637 (-3.17%)
CRDF : 3.03 (+5.21%)
VSTM : 8.31 (+11.10%)
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag Zacks Investment Research - Thu Jan 2, 10:18AM CST

Shares of Verastem Oncology VSTM rallied 40.9% on Tuesday after it announced that the FDA has accepted the new drug application (NDA) for its avutometinib/defactinib combo therapy to treat adult patients...

CTMX : 2.23 (+4.69%)
CSTL : 16.10 (+1.32%)
SPRO : 0.6963 (-0.24%)
VSTM : 8.31 (+11.10%)
Verastem: Q3 Earnings Snapshot AP - Wed Nov 6, 2024

Verastem: Q3 Earnings Snapshot

VSTM : 8.31 (+11.10%)
Verastem: Q2 Earnings Snapshot AP - Thu Aug 8, 2024

Verastem: Q2 Earnings Snapshot

VSTM : 8.31 (+11.10%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Newswire.ca - Wed Jun 12, 2024

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

ONCY : 0.4184 (+4.11%)
CADL : 5.43 (+0.18%)
FGEN : 0.3300 (+0.46%)
RHHBY : 39.6700 (+1.51%)
REGN : 588.34 (-1.43%)
ONC.TO : 0.55 (-1.79%)
VSTM : 8.31 (+11.10%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases BayStreet.ca - Wed Jun 12, 2024

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.4184 (+4.11%)
CADL : 5.43 (+0.18%)
FGEN : 0.3300 (+0.46%)
ONC.TO : 0.55 (-1.79%)
RHHBY : 39.6700 (+1.51%)
REGN : 588.34 (-1.43%)
VSTM : 8.31 (+11.10%)
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032 BayStreet.ca - Mon Jun 3, 2024

USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by focusing on earlier detection. According to Johns Hopkins...

ONCY : 0.4184 (+4.11%)
CTMX : 2.23 (+4.69%)
FGEN : 0.3300 (+0.46%)
ONC.TO : 0.55 (-1.79%)
VSTM : 8.31 (+11.10%)
BNTX : 98.68 (-0.39%)
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates Newswire.ca - Mon Jun 3, 2024

/CNW/ -- USA News Group – Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for pancreatic cancer patients by...

ONCY : 0.4184 (+4.11%)
CTMX : 2.23 (+4.69%)
FGEN : 0.3300 (+0.46%)
ONC.TO : 0.55 (-1.79%)
VSTM : 8.31 (+11.10%)
BNTX : 98.68 (-0.39%)

Barchart Exclusives

3 Highest-Yielding Dividend Stocks Worth Buying Today Barchart - Fri May 23, 6:00PM CDT
Want high-yield dividends without the risk? These three income-generating stocks offer up to 5.5% yield and strong upside, backed by Wall Street buy ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot